Neuropore Therapies is an innovative biopharmaceutical company utilizing structure-based drug-design technologies to discover novel therapies for Parkinson’s Disease, Alzheimer’s Disease, and related neurodegenerative disorders.  Neuropore has developed unique models of the processes by which the abnormal folding and deposition of neuronal proteins leads to synaptic dysfunction and cell death in these disorders.  Using these technologies and models,  Neuropore has discovered drug-like orally bioavailable compounds that block these pathological processes and dramatically improve outcomes in animal models. Neuropore is advancing it’s lead compounds through preclinical development with the goal of bringing potential new treatments for neurodegenerative disorders into clinical trial.